|Articles|June 1, 2013
- BioPharm International-06-01-2013
- Volume 26
- Issue 6
BioPharm International, June 2013 Issue (PDF)
Click the title above to open the BioPharm International June 2013 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 12 years ago
Using Plastic for Parenteral Containersover 12 years ago
Congress Considers Legislation to Secure Drug Supply Chainover 12 years ago
Drug Approval Trends Don't Extend to CMOsover 12 years ago
A Lifecycle Approach to Process Validationover 12 years ago
Report from Taiwanover 12 years ago
Trust in the Pill Bottleover 12 years ago
Flexibility in Biopharmaceutical Manufacturingover 12 years ago
Navigating Emerging Markets: Southeast AsiaNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New $82 Million Biopharma Launch Targets Rare Disease Development With AI-Driven Strategy
2
Next-Generation Modalities Drive New Antibody Discovery
3
European Approval of Donidalorsen Expands RNA-Targeted Prevention Strategies for HAE
4
GSK Acquisition of RAPT Signals Shift Toward Long-Acting Anti-IgE Therapies
5
